亞太基因組癌症面板和分析市場:按應用、最終用戶、國家:分析和預測(2023-2033)
市場調查報告書
商品編碼
1484376

亞太基因組癌症面板和分析市場:按應用、最終用戶、國家:分析和預測(2023-2033)

Asia-Pacific Genomic Cancer Panel and Profiling Market: Focus on Application, End User, and Country - Analysis and Forecast, 2023-2033

出版日期: | 出版商: BIS Research | 英文 45 Pages | 商品交期: 1-5個工作天內

價格

亞太地區基因組癌症檢測和分析市場規模預計將從 2023 年的 15.6 億美元增至 2033 年的 47.8 億美元。

這一成長是由基因組研究的進步以及對癌症領域精準醫療的日益關注所推動的。

主要市場統計數據
預測期 2023-2033
2023年評估 15.6億美元
2033年預測 47.8億美元
複合年成長率 11.81%

在全部區域癌症發病率上升和個人化醫療日益普及的推動下,亞太地區基因組癌症檢測和分析市場正在顯著成長。基因組技術的進步和次世代定序(NGS)能力的擴展正在提高癌症診斷和治療策略的精確度,使治療能夠根據個體的基因譜進行客製化。政府和醫療機構正在增加對醫療基礎設施和基因組研究的投資,進一步推動市場擴張。此外,生物技術公司之間的合作正在促進先進基因組測試的普及。大眾對早期癌症檢測和標靶治療益處的認知不斷提高也支持了這一市場的成長,使亞太地區成為癌症基因組醫學領域的重要地區。

該報告研究了亞太地區基因組癌症組合和分析市場,並提供了市場概述,包括按應用、最終用戶、國家和進入市場的公司概況分類的趨勢。

目錄

執行摘要

第1章 市場

  • 產品定義
  • 納入與排除標準
  • 市場範圍
  • 調查方法
  • 市場概況

第2章 按地區分類

  • 概述
  • 亞太地區

第3章 公司簡介

  • Burning Rock DX
  • Genecast Biotechnology Co., Ltd
Product Code: BHP2084SS

Introduction to Asia-Pacific Genomic Cancer Panel and Profiling Market

The Asia-Pacific genomic cancer panel and profiling market is expected to reach $4.78 billion by 2033 from $1.56 billion in 2023. This growth is driven by advancements in genomic research and an increasing focus on precision medicine within the field of oncology.

KEY MARKET STATISTICS
Forecast Period2023 - 2033
2023 Evaluation$1.56 Billion
2033 Forecast$4.78 Billion
CAGR11.81%

Market Introduction

The Asia-Pacific (APAC) Genomic Cancer Panel and Profiling Market is experiencing significant growth, propelled by the rising incidence of cancer and the increasing adoption of personalized medicine across the region. Advances in genomic technologies and the expanding capabilities of next-generation sequencing (NGS) have enhanced the precision of cancer diagnostics and treatment strategies, catering specifically to individual genetic profiles. Governments and healthcare institutions are increasingly investing in healthcare infrastructure and genomic research, further stimulating market expansion. Moreover, collaborations between biotech firms are boosting access to advanced genomic tests. This market's growth is also supported by growing public awareness about the benefits of early cancer detection and targeted therapies, making the APAC region a vital player in the landscape of cancer genomics.

Market Segmentation

Segmentation 1: by Application

  • Clinical
  • Research

Segmentation 2: by End User

  • Hospitals
  • Clinical and Diagnostic Laboratories
  • Research and Academic Institutes
  • Other End Users

Segmentation 3: by Country

  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Rest-of-Asia-Pacific

How can this report add value to an organization?

Product/Innovation Strategy: The Asia-Pacific genomic cancer panel and profiling market has been extensively segmented based on various categories, such as application, end user, and country. This can help readers get a clear overview of the segments accounting for the largest share and the ones that are well-positioned to grow in the coming years.

Key Market Players and Competition Synopsis

The companies that are profiled have been selected based on inputs gathered from primary experts and analyzing company coverage, product portfolio, and regional presence.

Some of the prominent names in this market are:

  • Burning Rock DX
  • Genecast Biotechnology Co., Ltd

Table of Contents

Executive Summary

1 Markets

  • 1.1 Product Definition
  • 1.2 Inclusion and Exclusion Criteria
    • 1.2.1 Inclusion Criteria
    • 1.2.2 Exclusion Criteria
  • 1.3 Market Scope
    • 1.3.1 Scope of the Study
    • 1.3.2 Key Questions Answered in this Report
  • 1.4 Research Methodology
    • 1.4.1 Genomic Cancer Panel and Profiling Market: Research Methodology
    • 1.4.2 Data Sources
    • 1.4.3 Market Estimation Model
    • 1.4.4 Criteria for Company Profiling
  • 1.5 Market Overview
    • 1.5.1 Market Definition
    • 1.5.2 Market Footprint and Growth Potential
    • 1.5.3 Future Potential

2 By Region

  • 2.1 Overview
  • 2.2 Asia-Pacific
    • 2.2.1 Key Dynamics
    • 2.2.2 China
    • 2.2.3 Japan
    • 2.2.4 India
    • 2.2.5 Australia
    • 2.2.6 South Korea
    • 2.2.7 Rest-of-Asia-Pacific

3 Company Profiles

  • 3.1 Overview
  • 3.2 Burning Rock DX
    • 3.2.1 Company Overview
    • 3.2.2 Role of Burning Rock DX in the Genomic Cancer Panel and Profiling Market
    • 3.2.3 Business Strategies
    • 3.2.4 Analyst Perspective
  • 3.3 Genecast Biotechnology Co., Ltd
    • 3.3.1 Company Overview
    • 3.3.2 Role of Genecast Biotechnology Co., Ltd in the Genomic Cancer Panel and Profiling Market
    • 3.3.3 Analyst Perspective

List of Figures

  • Figure 1: Asia-Pacific Genomic Cancer Panel and Profiling Market, $Billion, 2022-2033
  • Figure 2: Asia-Pacific Genomic Cancer Panel and Profiling Market (by Application), % Share, 2022 and 2033
  • Figure 3: Asia-Pacific Genomic Cancer Panel and Profiling Market (by End User), % Share 2022 and 2033
  • Figure 4: Genomic Cancer Panel and Profiling Market Snapshot (by Region), $Billion, 2022
  • Figure 5: Genomic Cancer Panel and Profiling Market Segmentation
  • Figure 6: Genomic Cancer Panel and Profiling Market: Research Methodology
  • Figure 7: Primary Research Methodology
  • Figure 8: Bottom-Up Approach (Segment-Wise Analysis)
  • Figure 9: Top-Down Approach (Segment-Wise Analysis)
  • Figure 10: Genomic Cancer Panel and Profiling Workflow, End User Perspective
  • Figure 11: Genomic Cancer Panel and Profiling Workflow, Laboratory Technician Perspective
  • Figure 12: Genomic Cancer Panel and Profiling Market, $Billion, 2022-2033
  • Figure 13: Genomic Cancer Panel and Profiling Market Snapshot (by Region), $Billion, 2022
  • Figure 14: Asia-Pacific Genomic Cancer Panel and Profiling Market, $Billion, 2022-2033
  • Figure 15: Asia-Pacific Genomic Cancer Panel and Profiling Market (by Application), $Million, 2022-2033
  • Figure 16: Asia-Pacific Genomic Cancer Panel and Profiling Market (by End User), $Million, 2022-2033
  • Figure 17: Asia-Pacific Genomic Cancer Panel and Profiling Market (by Country), $Billion, 2022-2033
  • Figure 18: China Genomic Cancer Panel and Profiling Market, $Million, 2022-2033
  • Figure 19: Japan Genomic Cancer Panel and Profiling Market, $Million, 2022-2033
  • Figure 20: India Genomic Cancer Panel and Profiling Market, $Million, 2022-2033
  • Figure 21: Australia Genomic Cancer Panel and Profiling Market, $Million, 2022-2033
  • Figure 22: South Korea Genomic Cancer Panel and Profiling Market, $Million, 2022-2033
  • Figure 23: Rest-of-Asia-Pacific Genomic Cancer Panel and Profiling Market, $Million, 2022-2033
  • Figure 24: Genomic Cancer Panel and Profiling Market, Total Number of Companies Profiled
  • Figure 25: Burning Rock DX: Product Portfolio
  • Figure 26: Genecast Biotechnology Co., Ltd: Product Portfolio

List of Tables

  • Table 1: Technological Trends in the Genomic Cancer Panel and Profiling Market
  • Table 2: Asia-Pacific Genomic Cancer Panel and Profiling Market, Impact Analysis